VACCINE AND TREATMENT EVALUATION UNIT: POPULATION PHARMACOKINETIC ANALYSES

疫苗和治疗评估单位：群体药代动力学分析

• 批准号: 9571751
• 负责人: KAREN KOTLOFF
• 金额: $ 139.77万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-11-07 至 2020-08-06
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9571751
• 关键词: Antimicrobial Resistance; Biological Assay; Communicable Diseases; Conduct Clinical Trials; Contracts; Drug Kinetics; Evaluation; Gram-Negative Bacteria; Individual; Population; Resources; Therapeutic; Vaccines; combat; design; named group; programs; protocol development

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的个人合同联盟组成，为临床试验的设计和实施提供现成的资源，以评估有前景的抗击传染病的产品。一般来说，产品会在正常健康人群中进行评估；然而，也可以接触特殊人群。